Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why do you keep patting yourself on the back when it was stated in the initial press release by the company that they had several options to choose from, a merger just being one of them.
You did not predict anything. It was in the press release.
And like I have been stating all along, this stock is priced solely on its cash reserves, not its technology
My AVG is $0.7. 2 weeks ago EDGE spike $1.05 in just 10 min pre market trading. what Do you think happens if definitiv R/M and pipeline News coming out next? $3 $4 $5? i am full with EDGE shares. probablY more shares like all ihub posters here together and i am so happy. In my history i have so many multipler traded. I am enjoy the calm before storm sudden start. you will very soon understand why i am load and hold EDGE. few month ago i have post EDGE works on R/M. read back and read your statement to my post i also was right. let me surprise. If we sudden see the pending milestone News we will see a monsta gap and run i think. EDGE for me next NASDAQ biotech multipler
Be honest
How far has the stock falling since first mentioned here as a buy?
EDGE close before massiv boooommmmmmm imho. definitiv R/M Update + News for Pipeline next imho.
There's no such thing as a final bottom
EDGE created a New 52-week low $0.45 yesterday! We should see A Series Of New 52-week lows until it hits its Final Bottom $0.40 unless those $0.4999 ~ $0.45 buyers push it up again!
We believe that PDS represents an attractive merger partner for Edge as PDS prepares to advance multiple late-stage clinical programs through key milestones in 2019 and beyond.”
Growing Product Pipeline
PDS Biotechnology is developing PDS0101 for the treatment of multiple human papilloma virus (HPV)-induced cancers, including cervical, anal and head and neck cancers. PDS Biotechnology plans to initiate multiple Phase 2/3 clinical trials for PDS0101 in HPV-associated cancers.
In a Phase 1/2a dose-escalating study of PDS0101, results confirmed preclinical projections of high levels of active HPV-specific killer T-cells (CD8+) and memory T-cell induction. In addition, T-cell responses were independent of patient genetic/HLA sub-types. In the study, no dose-limiting toxicities were observed.
In addition to PDS0101, PDS Biotechnology’s pipeline includes multiple preclinical programs developing Versamune®-based cancer immunotherapies in combination with checkpoint inhibitors for various late-stage cancers.
excample EBIO BCRX SEDG all NASDAQ 10 bagger turn around invests from me last years. EDGE next imho. All over same game. All cry i am wrong and some time later i sell with many $100.000 Profit. let you surprise. I also said EDGE works on R/M and you and all other posters here said EDGE dead and without chance to R/M. And now R/M official close before done. the time will tell the story. EDGE can start huge pop any day imho. wait for PR
At what price point will you can see that you are wrong? $0.20?
EDGE Therapeutics, Privately Held PDS Biotech Announce Reverse Merger
by Shanthi Rexalinea day ago
EDGE
Penny stock Edge Therapeutics Inc (NASDAQ: EDGE) is seeing strong buying interest Monday following the announcement of a merger agreement.
The stock was trading up by 4.31 percent to 73 cents at the time of publication.
What Happened
Edge Therapeutics announced its intention to merge with the privately held, clinical-stage cancer immunotherapy company PDS Biotechnology Corp. The boards of both companies approved the proposed transaction, the companies said in a joint press release.
The reverse merger deal is structured as a stock-for-stock transaction in which all PDS shares would be converted into Edge common stock, with the exchange ratio suggesting that immediately following the merger, PDS shareholders will own about 70 percent of the combined company and existing Edge shareholders will hold the remainder.
A reverse merger deal is a transaction in which an active private company merges with a dormant public company in a bid to go public without having to go through the arduous route of a traditional initial public offering.
Edge announced a comprehensive review of strategic alternatives in April in a bid to maximize shareholder value. The decision followed a failed late-stage trial of its aneurysmal subarachnoid hemorrhages treatment candidate, which subsequently forced the company to announce layoffs.
Why It's Important
Edge sees the merger as facilitating the creation of a publicly traded immuno-oncology company that develops novel products to treat early- and late-stage cancer.
PDS Biotech's lead candidate PDS101 has demonstrated immunotherapeutic anti-cancer activity and a favorable safety profile in early stage cervical cancer in a Phase 1/2 clinical trial.
"We expect that the combined company will have the financial resources and experienced leadership to accomplish our key near-term objectives: first, to initiate multiple late-stage clinical studies for our lead product candidate PDS0101; and second, to further advance our preclinical programs toward the clinic," PDS CEO Frank Bedu-Addo said in a statement.
What's Next
The deal is expected to close in the first quarter of 2019.
Following the consummation of the deal, the merged entity will function under the name PDS Biotechnology Corp., with the shares of the combined company to be listed on the Nasdaq under a new ticker symbol to be announced at a later date.
On the pipeline front, the combined company plans to initiate Phase 2b/3 clinical trials of PDS101 in HPV-associated cancers.
over night multipler potential. EDGE is a big end of 2018 surprise imho
Definitiv R/M update can kick in any day. 200% gap and run then imho.. EDGE is my next 1000% biotech turn around stock.
EDGE trading has absolutely nothing to do with the overall indices
Weird, the USA stock market crashed today but EDGE only hit $0.4785 so far and its New Bottom $0.4701 seems hard to hit again while it should create A Series Of New 52-week lows until it hits its Final Bottom $0.40!
The most recent high $0.80 will be the Forever Top Ceiling price!
.48 worth of good mornings
Every single week for months, the same types of posts
Bounce setting... Next week EDGE boooommmm time with R/M update possible imho
The Pos Scam declined to $0.47 today! $0.400 should be tested as soon as next week! Anyway it is bouncing now and I'm selling my shares for small gain before it breaks down $0.47...
What is the current quote on EDGE and how much of a loss is one willing to take on this when it gets cut in half?
EDGE "REVERSE MERGER" breakout into new future. great future for shareholders imho looking forward for huge jump north next days/week
The company plans to initiate phase 2b/3 trials.
It is quite obvious that the company reverse merging into the sticker symbol is underfunded and is using Edge's remaining cash to help it get through its clinical trials. This certainly is not going to be any type of a fast turnaround play.
Huge R/M updates can kick in any time. R/M ahead. timebomb for 1000% turn around for me. EDGE
EDGE Therapeutics, Privately Held PDS Biotech Announce Reverse Merger
by Shanthi Rexalinea day ago
EDGE
Penny stock Edge Therapeutics Inc (NASDAQ: EDGE) is seeing strong buying interest Monday following the announcement of a merger agreement.
The stock was trading up by 4.31 percent to 73 cents at the time of publication.
What Happened
Edge Therapeutics announced its intention to merge with the privately held, clinical-stage cancer immunotherapy company PDS Biotechnology Corp. The boards of both companies approved the proposed transaction, the companies said in a joint press release.
The reverse merger deal is structured as a stock-for-stock transaction in which all PDS shares would be converted into Edge common stock, with the exchange ratio suggesting that immediately following the merger, PDS shareholders will own about 70 percent of the combined company and existing Edge shareholders will hold the remainder.
A reverse merger deal is a transaction in which an active private company merges with a dormant public company in a bid to go public without having to go through the arduous route of a traditional initial public offering.
Edge announced a comprehensive review of strategic alternatives in April in a bid to maximize shareholder value. The decision followed a failed late-stage trial of its aneurysmal subarachnoid hemorrhages treatment candidate, which subsequently forced the company to announce layoffs.
Why It's Important
Edge sees the merger as facilitating the creation of a publicly traded immuno-oncology company that develops novel products to treat early- and late-stage cancer.
PDS Biotech's lead candidate PDS101 has demonstrated immunotherapeutic anti-cancer activity and a favorable safety profile in early stage cervical cancer in a Phase 1/2 clinical trial.
"We expect that the combined company will have the financial resources and experienced leadership to accomplish our key near-term objectives: first, to initiate multiple late-stage clinical studies for our lead product candidate PDS0101; and second, to further advance our preclinical programs toward the clinic," PDS CEO Frank Bedu-Addo said in a statement.
What's Next
The deal is expected to close in the first quarter of 2019.
Following the consummation of the deal, the merged entity will function under the name PDS Biotechnology Corp., with the shares of the combined company to be listed on the Nasdaq under a new ticker symbol to be announced at a later date.
On the pipeline front, the combined company plans to initiate Phase 2b/3 clinical trials of PDS101 in HPV-associated cancers.
The Pos Scam declined to $0.5108 so far! Its current Bottom $0.5051 will be tested again as soon as today! Sell it ASAP before it is too late...
Anyway this early morning EDGE ever bounced to $0.56 with 8,100 shares!
i hold a $50.000 EDGE posotion for $5 $6 next weeks and months.
Yes, I took a small position for quick flipping since EDGE might crash to another New low $0.4xxx in the coming days/weeks...
Last evening it further declined to $0.529 (which is lower than yesterday's low $0.531) in AH!
The current Bottom $0.5051 should be tested again as soon as next week!
"for us"?????
You are a shareholder?
EDGE crashed to a New Lower daily low $0.529 so far in AH! It will further crash to its Real Bottom price $0.5051 again as soon as tomorrow...
Total 787,000 shares were shorted as of 11/29/2018! So the Short-Squeezing effect will not be very strong due to just small amount of shorted shares! By the way no any retail investors could short EDGE and only those institutions could short it!
Who are those very stupid buyers which bought EDGE at $1.02 ~ $0.81 most recently?
Anyway $0.5051 seems a Temporary Bottom price and the further decline is expected very soon! We might see $0.4xxx as soon as tomorrow...
Sell volume dryed out. Smart whales for sure have load this ultra cheap bottoms i think. this R/M is a jackpot for EDGE and i expect a 10 bagger as by my last BCRX EBIO biotech turn around incests.
This will continue to sell down as tax loss sellers continue to sell
Whomever is RM'ing with EDGE is doing so to tap into EDGE's remaining dwindling cash reserve
6m volume up friday ** 900k down yesterday + only 500k volume down today. tic toc... tomorrow makret close and next days EDGE start finaly after double bottom building yesterday+today. EDGE great R/M with huge potential now. for me save 1000% and more turn around ticket. let me surprise
Down an additional 6.2%
Not so much a good day or week for that matter
And if not, we can assuredly expect seeing the bipolarism
complete trading Day after the early morning selling without real sell vol. double bottom is in. EDGE now with finaly setting to bounce. R/M is fantastic and the future with new company and new pipeline great sound. EDGE next multipler for me.
Yes, it crashed because EDGE is an overhyped scam.
I received a promo email out of Berlin...
Instant scam warning.
Wow! Does anyone know why EDGE crashed to $0.56 today from $0.8? Hopefully $0.5051 will be the forever Bottom for all the shareholders!
friday on 8m vol. up and today on 1m volume setting. big money load EDGE. tic toc.....
why lol? Just a double bottom setting. perfect entry point imho. EDGE mulipler. let, you surprise for updates
perfect early morning dip to load some EDGE
Definately will have to add to my position as this is a cancer method I BELIEVE to be most promising
-- REVERSE MERGER -- only 2 words say it all whats up now with EDGE shell. multipler coming imho
agree, insiders control the most of o/s. EDGE going big now with this huge R/M future. $17 some month ago. $5 $6 short term very possible imho.
Followers
|
24
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1509
|
Created
|
09/30/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |